Amyloid-polysaccharide interfacial coacervates as therapeutic materials

Area of Science:

• Biomaterials Science
• Nanotechnology
• Polymer Chemistry

Background:

• Coacervation enables functional nanostructured biomaterials.
• Protein-polysaccharide coacervates are promising scaffolds but lack stability.
• Native protein instability limits their use in biomaterial applications.

Purpose of the Study:

• To overcome stability limitations in protein-polysaccharide coacervates.
• To develop novel biomaterials with controlled structure and properties.
• To explore the therapeutic potential of engineered coacervates.

Main Methods:

• Transforming native proteins into amyloid fibrils.
• Coacervation of cationic protein amyloids and anionic linear polysaccharides.
• Interfacial self-assembly to create asymmetric biomaterial architectures.
• In vivo assay for therapeutic efficacy in gastric ulcer protection.

Main Results:

• Amyloid-polysaccharide coacervates exhibit enhanced mechanical and chemical stability.
• Achieved precise control over biomaterial structure and properties.
• Demonstrated a highly ordered asymmetric architecture.
• Validated therapeutic effect for gastric ulcer protection using engineered microparticles.

Conclusions:

• Amyloid-polysaccharide coacervates represent a novel and stable biomaterial.
• These coacervates offer precise structural control and enhanced functionality.
• Engineered microparticles show significant potential for internal medicine applications, particularly in treating gastric ulcers.